Bruno SCHOENTJES;Julien Georges Pierre-Olivier DOYON;Joannes Theodorus Maria LINDERS;Luc August Laurentius VER DONCK;Lieven MEERPOEL;Alain Philippe PONCELET
发明人:
Bruno SCHOENTJES,Alain Philippe PONCELET,Julien Georges Pierre-Olivier DOYON,Joannes Theodorus Maria LINDERS,Lieven MEERPOEL,Luc August Laurentius VER DONCK
申请号：
US13597293
公开号：
US20120322796A1
申请日:
2012.08.29
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to a compound of formula (I)including any stereochemically isomeric form thereof, wherein the substituents are as defined in the specification and the claims； a N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof；provided that the compound is other thanor a pharmaceutically acceptable salt thereof.The claimed compounds are useful for the treatment of a disease, the treatment of which is affected, mediated or facilitated by activating the GHS1A-r receptor. The invention also relates to pharmaceutical compositions thereof and processes for the preparation thereof.
